Aster DM Healthcare Ltd. will conduct an "independent fact-finding" review on allegations of misconduct by senior employees by enlisting the services of Grant Thornton Bharat LLP, according to an exchange filing on Monday.
This audit was prompted by a complaint by an anonymous whistleblower who claimed senior members of the company were guilty of professional misconduct and some unethical practices. The company had disclosed this in an exchange filing on May 28.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
There was a "breach of conflict of interest policy" by certain employees, which included failure to disclose interest in or relationships with certain vendors of Aster, according to the initial filing.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
This took place in fiscal 2024, the company said.
This alleged fraud involved the vice president of the company, along with the head of projects and regional head of finance, at that time. It was estimated to have been for an amount of Rs 25 lakh.
The company reported that the concerned employees would be subject to disciplinary proceedings and that they have also formally apologised to the company and said that the lapses were due to oversight on their part. The relevant transactions resulting in the conflict of interest were being wound up, they said.
"The company has defined measures to strengthen its internal control systems. Adequate changes to the functional reporting structure will be put in place. The company will conduct training sessions for employees on the code of conduct and conflict of interest policy of the company," the filing said.
Shares of Aster DM Healthcare closed down 0.58% at Rs 337.10 apiece, compared to a 0.35% rise in the NSE Nifty 50.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
